Saturday . June 27, 2026

You are here

Home
moderna

moderna

Moderna announces executive changes ahead of potential launches

Intismeran is Moderna’s lead mRNA-based cancer vaccine developed in collaboration with Merck
Moderna expects important clinical milestones ⁠this year

By Reuters · 16 June 2026

EU regulator backs approval for Moderna’s combined COVID and flu vaccine

By Reuters · 27 February 2026

US FDA approves Moderna’s next-generation COVID-19 vaccine for adults 65 or older

By Reuters · 31 May 2025

Moderna pulls application for COVID-flu combination shot

By Reuters · 21 May 2025

World not prepared for another pandemic: Moderna chairman

By Natalia Laskowska · 07 December 2023

Moderna plans regional expansion in 5 years, top official tell Arab News

By Reina Takla - Reem Walid · 10 June 2023

Moderna says potential flu vaccine needs more study

By AP · 11 April 2023

Moderna flu vaccine delivers mixed results in trial, shares fall

By Reuters · 17 February 2023

Merck, Moderna detail potential skin cancer vaccine progress

By AP · 13 December 2022

Moderna sues Pfizer/BioNTech for patent infringement over COVID vaccine

By Reuters · 26 August 2022

US approves Pfizer and Moderna vaccines for youngest children

By AFP · 17 June 2022

Britain approves Moderna’s COVID shot for children aged six and older

By Reuters · 14 April 2022

Moderna says infant Covid vaccine succeeded in trial

By AFP · 23 March 2022

Print Edition

Read pdf version Subscribe now

© 2026 SAUDI RESEARCH & PUBLISHING COMPANY, All Rights Reserved And subject to Terms of Use Agreement.